title: Reversion of cerebral artery stenoses due to tuberculomas with TNF-α antibodies.
authors.affiliation: Department Internal Medicine, Division of Nephrology and Infectious diseases, AZ Sint-Jan Brugge-Oostende AV, Ruddershove 10, 8000 Brugge, Belgium. Stefaan.Vandecasteele@azbrugge.be
authors.forename: Stefaan J
authors.initials: SJ
authors.lastname: Vandecasteele
authors.forename: An S
authors.initials: AS
authors.lastname: De Vriese
authors.forename: Geert T
authors.initials: GT
authors.lastname: Vanhooren
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002533:Cerebral Angiography; D002539:Cerebral Arterial Diseases / Q000000981:diagnostic imaging / Q000209:etiology* / Q000276:immunology*; D003251:Constriction, Pathologic / Q000209:etiology / Q000276:immunology; D004401:Dysarthria / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D011149:Pons / Q000473:pathology; D049268:Positron-Emission Tomography; D014375:Tuberculoma / Q000000981:diagnostic imaging / Q000209:etiology* / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*; D014715:Vertebrobasilar Insufficiency / Q000000981:diagnostic imaging / Q000209:etiology / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab